The genetic basis of the comorbidity between cannabis use and major depression

Addiction

Volumn 112, Issue 1, 2017, Pages 113-123

  Hodgson, Karen ^a   Almasy, Laura ^b   Knowles, Emma E M ^a   Kent, Jack W ^c   Curran, Joanne E ^b   Dyer, Thomas D ^b   Göring, Harald H H ^b   Olvera, Rene L ^d   Woolsey, Mary D ^b   Duggirala, Ravi ^b   Fox, Peter T ^b,e   Blangero, John ^b   Glahn, David C ^a,f  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^d Mays Cancer Center at UT Health San Antonio   (United States)

^e SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

^f HARTFORD HOSPITAL   (United States)

Author keywords

Cannabis; comorbidity; genetics; linkage; major depression; pleiotropy

Indexed keywords

ADOLESCENT; ADULT; AGED; CANNABIS ADDICTION; COMORBIDITY; ETHNIC GROUP; FEMALE; GENETIC PREDISPOSITION; GENETICS; HUMAN; MAJOR DEPRESSION; MALE; MIDDLE AGED; PSYCHOLOGY; STATISTICS AND NUMERICAL DATA; TEXAS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COMORBIDITY; DEPRESSIVE DISORDER, MAJOR; ETHNIC GROUPS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MARIJUANA ABUSE; MIDDLE AGED; TEXAS; YOUNG ADULT;

EID: 84988909679     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/add.13558     Document Type: Article

References (78)

1. United Nations Office on Drugs and Crime (UNODC). World Drug Report 2015. United Nations publication. Vienna: UNODC; 2015; pp. 1–117.
2. Substance Abuse and Mental Health Services Administration (SAMHSA). Results From the 2013 National Survey on Drug Use and Health: Summary of National Findings. Vol. NSDUH Series, Substance Abuse. Rockville, MD: SAMHSA; 2014. Available at: http://oas.samhsa.gov/NSDUH/2k10NSDUH/2k10Results.pdf (accessed 29 January 2016).
3. Lev-Ran S., Roerecke M., Le Foll B., George T. P., McKenzie K., Rehm J. The association between cannabis use and depression: a systematic review and meta-analysis of longitudinal studies. Psychol Med 2014; 44: 797–810.
4. Chen C.-Y., Wagner F. A., Anthony J. C. Marijuana use and the risk of Major Depressive Episode. Epidemiological evidence from the United States National Comorbidity Survey. Soc Psychiatry Psychiatr Epidemiol 2002; 37: 199–206.
5. Moore T. H. M., Zammit S., Lingford-Hughes A., Barnes T. R. E., Jones P. B., Burke M. et al. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 2007; 370: 319–28.
6. Davis L. L., Frazier E., Husain M. M., Warden D., Trivedi M., Fava M. et al. Substance use disorder comorbidity in major depressive disorder: a confirmatory analysis of the STAR*D cohort. Am J Addict 2006; 15: 278–85.
7. Degenhardt L., Hall W., Lynskey M. Exploring the association between cannabis use and depression. Addiction 2003; 98: 1493–504.
8. Khantzian E. J. The Self-Medication Hypothesis of Substance Use Disorders: A Reconsideration and Recent Applications. Harvard Review of Psychiatry: Chichester, UK: Taylor & Francis; 2015.
9. Bolton J. M., Robinson J., Sareen J. Self-medication of mood disorders with alcohol and drugs in the National Epidemiologic Survey on Alcohol and Related Conditions. J Affect Disord 2009; 115: 367–75.
10. Bovasso G. B. Cannabis Abuse as a Risk Factor for Depressive Symptoms. Am J Psychiatry 2001; 158: 2033–7.
11. Sullivan P. F., Neale M. C., Kendler K. S. Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry 2000; 157: 1552–62.
12. Verweij K. J. H., Zietsch B. P., Lynskey M. T., Medland S. E., Neale M. C., Martin N. G. et al. Genetic and environmental influences on cannabis use initiation and problematic use: a meta-analysis of twin studies. Addiction 2010; 105: 417–30.
13. Lynskey M. T., Glowinski A. L., Todorov A. A., Bucholz K. K., Madden P. A. F., Nelson E. C. et al. Major depressive disorder, suicidal ideation, and suicide attempt in twins discordant for cannabis dependence and early-onset cannabis use. Arch Gen Psychiatry 2004; 61: 1026–32.
14. Marmorstein N. R., Iacono W. G., McGue M. Associations between substance use disorders and major depression in parents and late adolescent-emerging adult offspring: an adoption study. Addiction 2012; 107: 1965–73.
15. Fu Q., Heath A. C., Bucholz K. K., Nelson E., Goldberg J., Lyons M. J. et al. Shared genetic risk of major depression, alcohol dependence, and marijuana dependence: contribution of antisocial personality disorder in men. Arch Gen Psychiatry 2002; 59: 1125–32.
16. Sherva R., Wang Q., Kranzler H., Zhao H., Koesterer R., Herman A. et al. Genome-wide association study of cannabis dependence severity, novel risk variants, and shared genetic risks. JAMA Psychiatry 2016; 73: 472–80.
17. Ripke S., Wray N. R., Lewis C. M., Hamilton S. P., Weissman M. M., Breen G. et al. A mega-analysis of genome-wide association studies for major depressive disorder. Mol Psychiatry 2013; 18: 497–11.
18. CONVERGE Consortium. Sparse whole-genome sequencing identifies two loci for major depressive disorder. Nature 2015; 523: 588–91.
19. Borecki I. B., Province M. A. Genetic and genomic discovery using family studies. Circulation 2008; 118: 1057–63.
20. Breen G., Webb B. T., Butler A. W., van den Oord E. J. C. G., Tozzi F., Craddock N. et al. A genome-wide significant linkage for severe depression on chromosome 3: the depression network study. Am J Psychiatry 2011; 168: 840–7.
21. Pergadia M. L., Glowinski A. L., Wray N. R., Agrawal A., Saccone S. F., Loukola A. et al. A 3p26-3p25 genetic linkage finding for DSM-IV major depression in heavy smoking families. Am J Psychiatry 2011; 168: 848–52.
22. Stringer S., Minică C. C., Verweij K. J. H., Mbarek H., Bernard M., Derringer J. et al. Genome-wide association study of lifetime cannabis use based on a large meta-analytic sample of 32 330 subjects from the International Cannabis Consortium. Transl Psychiatry 2016; 6: e769.
23. Agrawal A., Lynskey M. T. Candidate genes for cannabis use disorders: findings, challenges and directions. Addiction 2009; 104: 518–320.
24. Ehlers C. L., Gizer I. R., Vieten C., Wilhelmsen K. C. Linkage analyses of cannabis dependence, craving, and withdrawal in the San Francisco family study. Am J Med Genet B Neuropsychiatr Genet 2010; 153B: 802–11.
25. Han S., Yang B.-Z., Kranzler H. R., Oslin D., Anton R., Farrer L. A. et al. Linkage analysis followed by association show NRG1 associated with cannabis dependence in African Americans. Biol Psychiatry 2012; 72: 637–44.
26. Almasy L., Dyer T. D., Blangero J. Bivariate quantitative trait linkage analysis: pleiotropy versus co-incident linkages. Genet Epidemiol 1997; 14: 953–8.
27. Berkson J. Limitations of the Application of Fourfold Table Analysis to Hospital Data. Biometrics Bull 1946; 2: 47–53.
28. Galbaud du Fort G., Newman S. C., Bland R. C. Psychiatric comorbidity and treatment seeking. Sources of selection bias in the study of clinical populations. J Nerv Ment Dis 1993; 181: 467–74.
29. US Census Bureau. Census 2014. Suitland, MD: US Census Bureau; 2014.
30. Beuten J., Halder I., Fowler S. P., Groing H. H. H., Duggirala R., Arya R. et al. Wide disparity in genetic admixture among Mexican Americans from San Antonio, TX. Ann Hum Genet 2011; 75: 529–38.
31. McPeek M. S., Sun L. Statistical tests for detection of misspecified relationships by use of genome-screen data. Am J Hum Genet 2000; 66: 1076–94.
32. Olvera R. L., Bearden C. E., Velligan D. I., Almasy L., Carless M. A., Curran J. E. et al. Common genetic influences on depression, alcohol, and substance use disorders in Mexican-American families. Am J Med Genet B Neuropsychiatr Genet 2011; 156B: 561–8.
33. McKay D. R., Knowles E. E. M., Winkler A. A. M., Sprooten E., Kochunov P., Olvera R. L. et al. Influence of age, sex and genetic factors on the human brain. Brain Imaging Behav 2014; 8: 143–52.
34. Sheehan D. V., Lecrubier Y., Sheehan K. H., Amorim P., Janavs J., Weiller E. et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59: 22–33. quiz 34–57.
35. Evans D. M., Cardon L. R. Guidelines for genotyping in genomewide linkage studies: single-nucleotide-polymorphism maps versus microsatellite maps. Am J Hum Genet 2004; 75: 687–92.
36. Heath S. C. Markov chain Monte Carlo segregation and linkage analysis for oligogenic models. Am J Hum Genet 1997; 61: 748–60.
37. Almasy L., Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 1998; 62: 1198–211.
38. Duggirala R., Williams J. T., Williams-Blangero S., Blangero J. A variance component approach to dichotomous trait linkage analysis using a threshold model. Genet Epidemiol 1997; 14: 987–92.
39. Williams J. T., Blangero J. Power of variance component linkage analysis to detect quantitative trait loci. Ann Hum Genet 1999; 63: 545–63.
40. Feingold E., Brown P. O., Siegmund D. Gaussian models for genetic linkage analysis using complete high-resolution maps of identity by descent. Am J Hum Genet 1993; 53: 234–51.
41. Knowles E. E. M., Carless M. A., de Almeida M. A. A., Curran J. E., McKay D. R., Sprooten E. et al. Genome-wide significant localization for working and spatial memory: Identifying genes for psychosis using models of cognition. Am J Med Genet B Neuropsychiatr Genet 2014; 165B: 84–95.
42. Williams J. T., Begleiter H., Porjesz B., Edenberg H. J., Foroud T., Reich T. et al. Joint multipoint linkage analysis of multivariate qualitative and quantitative traits. II. Alcoholism and event-related potentials. Am J Hum Genet 1999; 65: 1148–60.
43. Moskvina V., Schmidt K. M. On multiple-testing correction in genome-wide association studies. Genet Epidemiol 2008; 32: 567–73.
44. Kobrynski L. J., Sullivan K. E. Velocardiofacial syndrome, DiGeorge syndrome: the chromosome 22q11.2 deletion syndromes. Lancet 2007; 370: 1443–52.
45. Maynard T. M., Haskell G. T., Peters A. Z., Sikich L., Lieberman J. A., LaMantia A.-S. A comprehensive analysis of 22q11 gene expression in the developing and adult brain. Proc Natl Acad Sci USA 2003; 100: 14433–8.
46. Schneider M., Debbané M., Bassett A. S., Chow E. W. C., Fung W. L. A., van den Bree M. et al. Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome. Am J Psychiatry 2014; 171: 627–39.
47. Wise R. A. Dopamine, learning and motivation. Nat Rev Neurosci 2004; 5: 483–94.
48. Volkow N. D., Wang G.-J., Fowler J. S., Tomasi D., Telang F. Addiction: beyond dopamine reward circuitry. Proc Natl Acad Sci USA 2011; 108: 15037–42.
49. Bossong M. G., van Berckel B. N. M., Boellaard R., Zuurman L., Schuit R. C., Windhorst A. D. et al. Delta 9-tetrahydrocannabinol induces dopamine release in the human striatum. Neuropsychopharmacology 2009; 34: 759–66.
50. Theodosis D. T., Bonhomme R., Vitiello S., Rougon G., Poulain D. A. Cell surface expression of polysialic acid on NCAM is a prerequisite for activity-dependent morphological neuronal and glial plasticity. J Neurosci 1999; 19: 10228–36.
51. Conboy L., Bisaz R., Markram K., Sandi C. Role of NCAM in emotion and learning. Adv Exp Med Biol 2010; 663: 271–96.
52. Barker J. M., Torregrossa M. M., Taylor J. R. Low prefrontal PSA-NCAM confers risk for alcoholism-related behavior. Nat Neurosci 2012; 15: 1356–8.
53. Gómez M., Hernández M., Johansson B., de Miguel R., Ramos J. A., Fernández-Ruiz J. Prenatal cannabinoid exposure and gene expression for neural adhesion molecule L1 in the fetal rat brain. Dev Brain Res 2003; 147: 201–7.
54. Weber M., Modemann S., Schipper P., Trauer H., Franke H., Illes P. et al. Increased polysialic acid neural cell adhesion molecule expression in human hippocampus of heroin addicts. Neuroscience 2006; 138: 1215–23.
55. Duman R. S., Monteggia L. M. A neurotrophic model for stress-related mood disorders. Biol Psychiatry 2006; 59: 1116–27.
56. Castrén E. Is mood chemistry? Nat Rev Neurosci 2005; 6: 241–6.
57. Aonurm-Helm A., Jurgenson M., Zharkovsky T., Sonn K., Berezin V., Bock E. et al. Depression-like behaviour in neural cell adhesion molecule (NCAM)-deficient mice and its reversal by an NCAM-derived peptide, FGL. Eur J Neurosci 2008; 28: 1618–28.
58. Poltorak M., Frye M. A., Wright R., Hemperly J. J., George M. S., Pazzaglia P. J. et al. Increased neural cell adhesion molecule in the CSF of patients with mood disorder. J Neurochem 2002; 66: 1532–8.
59. Maheu M. E., Davoli M. A., Turecki G., Mechawar N. Amygdalar expression of proteins associated with neuroplasticity in major depression and suicide. J Psychiatr Res 2013; 47: 384–90.
60. Neville M. J., Johnstone E. C., Walton R. T. Identification and characterization of ANKK1: a novel kinase gene closely linked to DRD2 on chromosome band 11q23.1. Hum Mutat 2004; 23: 540–5.
61. Munafò M. R., Timpson N. J., David S. P., Ebrahim S., Lawlor D. A. Association of the DRD2 gene Taq1A polymorphism and smoking behavior: a meta-analysis and new data. Nicotine Tob Res 2009; 11: 64–76.
62. Ohmoto M., Sakaishi K., Hama A., Morita A., Nomura M., Mitsumoto Y. Association between dopamine receptor 2 TaqIA polymorphisms and smoking behavior with an influence of ethnicity: a systematic review and meta-analysis update. Nicotine Tob Res 2013; 15: 633–42.
63. Munafò M. R., Matheson I. J., Flint J. Association of the DRD2 gene Taq1A polymorphism and alcoholism: a meta-analysis of case–control studies and evidence of publication bias. Mol Psychiatry 2007; 12: 454–61.
64. Wang F., Simen A., Arias A., Lu Q.-W., Zhang H. A large-scale meta-analysis of the association between the ANKK1/DRD2 Taq1A polymorphism and alcohol dependence. Hum Genet 2013; 132: 347–58.
65. Yang B.-Z., Kranzler H. R., Zhao H., Gruen J. R., Luo X., Gelernter J. Association of haplotypic variants in DRD2, ANKK1, TTC12 and NCAM1 to alcohol dependence in independent case control and family samples. Hum Mol Genet 2007; 16: 2844–53.
66. Gelernter J., Yu Y., Weiss R., Brady K., Panhuysen C., Yang B.-Z. et al. Haplotype spanning TTC12 and ANKK1, flanked by the DRD2 and NCAM1 loci, is strongly associated to nicotine dependence in two distinct American populations. Hum Mol Genet 2006; 15: 3498–507.
67. Yang B.-Z., Kranzler H. R., Zhao H., Gruen J. R., Luo X., Gelernter J. Haplotypic variants in DRD2, ANKK1, TTC12, and NCAM1 are associated with comorbid alcohol and drug dependence. Alcohol Clin Exp Res 2008; 32: 2117–27.
68. Abecasis G. R., Auton A., Brooks L. D., DePristo M. A., Durbin R. M., Handsaker R. E. et al. An integrated map of genetic variation from 1,092 human genomes. Nature 2012; 491: 56–65.
69. Ehlers C. L., Gilder D. A., Gizer I. R., Wilhelmsen K. C. Heritability and a genome-wide linkage analysis of a Type II/B cluster construct for cannabis dependence in an American Indian community. Addict Biol 2009; 14: 338–48.
70. Verweij K. J. H., Vinkhuyzen A. A. E., Benyamin B., Lynskey M. T., Quaye L., Agrawal A. et al. The genetic aetiology of cannabis use initiation: a meta-analysis of genome-wide association studies and a SNP-based heritability estimation. Addict Biol 2013; 18: 846–50.
71. Gur R. E., Nimgaonkar V. L., Almasy L., Calkins M. E., Ragland J. D., Pogue-Geile M. F. et al. Neurocognitive endophenotypes in a multiplex multigenerational family study of schizophrenia. Am J Psychiatry 2007; 164: 813–9.
72. United Nations Office on Drugs and Crime (UNODC). World Drug Report 2011. Vienna: UNODC; 2011.
73. Hasin D. S., Grant B. F. The National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) Waves 1 and 2: review and summary of findings. Soc Psychiatry Psychiatr Epidemiol 2015; 50: 1609–40.
74. Kessler R. C., Berglund P., Demler O., Jin R., Merikangas K. R., Walters E. E. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62: 593–602.
75. Alegría M., Canino G., Shrout P. E., Woo M., Duan N., Vila D. et al. Prevalence of mental illness in immigrant and non-immigrant U.S. Latino groups. Am J Psychiatry 2008; 165: 359–69.
76. Otiniano Verissimo A. D., Grella C. E., Amaro H., Gee G. C. Discrimination and substance use disorders among Latinos: the role of gender, nativity, and ethnicity. Am J Public Health 2014; 104: 1421–8.
77. Salas-Wright C. P., Clark T. T., Vaughn M. G., Córdova D. Profiles of acculturation among Hispanics in the United States: links with discrimination and substance use. Soc Psychiatry Psychiatr Epidemiol 2015; 50: 39–49.
78. Caetano R., Ramisetty-Mikler S., Rodriguez L. A. The Hispanic Americans Baseline Alcohol Survey (HABLAS): the association between birthplace, acculturation and alcohol abuse and dependence across Hispanic national groups. Drug Alcohol Depend 2009; 99: 215–21.